COGNUTRIN in Breast Cancer Survivors

NCT01823991 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: VitaBlue™
OTHER: Placebo
DRUG: Lovaza®

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]